Achillion Pharmaceuticals, Inc. (NASDAQ:ACHN) Receives Average Recommendation of “Hold” from Brokerages
Achillion Pharmaceuticals, Inc. (NASDAQ:ACHN) has received an average recommendation of “Hold” from the eight brokerages that are presently covering the company, MarketBeat reports. Three analysts have rated the stock with a sell recommendation, four have issued a hold recommendation and one has assigned a buy recommendation to the company. The average 12-month price objective among brokers that have issued ratings on the stock in the last year is $4.96.
A number of analysts recently commented on the company. ValuEngine upgraded Achillion Pharmaceuticals from a “sell” rating to a “hold” rating in a research report on Wednesday, October 16th. BidaskClub cut Achillion Pharmaceuticals from a “sell” rating to a “strong sell” rating in a research report on Saturday, December 21st. Leerink S ...